News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hickey Benjamin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 01/24/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 36,394 shares
@ $0
Granted 45,456 options to buy
@ $45.66, valued at
$2.1M
|
|
| 01/19/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 947 shares
@ $42.3779, valued at
$40.1k
Sold 619 shares
@ $42.3814, valued at
$26.2k
|
|
| 01/10/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 2,088 shares
@ $45.37, valued at
$94.7k
|
|
| 12/21/2022 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 19,149 shares
@ $0
Sold 3,248 shares
@ $40.4143, valued at
$131.3k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 10,755 shares
@ $0
Sold 627 shares
@ $120.4828, valued at
$75.5k
Granted 17,821 options to buy
@ $124.31, valued at
$2.2M
|
|
| 01/07/2022 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 1,964 shares
@ $135.9389, valued at
$267k
|
|
| 01/05/2022 |
4
| Hickey Benjamin (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 24,000 options to buy
@ $5.08, valued at
$121.9k
|
|
| 12/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/22/2021 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 588 shares
@ $175.5367, valued at
$103.2k
Sold 1,350 shares
@ $176.4229, valued at
$238.2k
Sold 431 shares
@ $177.7056, valued at
$76.6k
Exercised 2,369 options to buy
@ $114.33, valued at
$270.8k
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2019 |
4
| Hickey Benjamin (SVP, Chief Commerical Officer) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 6,990 shares
@ $15.46, valued at
$108.1k
Exercised 20,216 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2018 |
3
| Hickey Benjamin (SVP, Chief Commercial Officer) has filed a Form 3 on HALOZYME THERAPEUTICS INC |
|
|